Zhu Chenghua, Yang Ning, Yao Jing, Du Xingran
Department of Respiratory and Critical Care Medicine, The Second Affifiliated Hospital of Nanjing Medical University, Nanjing, China.
Department of Respiratory and Critical Care Medicine, The Affifiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
Case Rep Oncol. 2024 Jan 16;17(1):101-106. doi: 10.1159/000535985. eCollection 2024 Jan-Dec.
Primary pleural epithelial angiosarcoma (EAS) is an extremely rare tumor with no specific clinical symptoms. Clinical data on primary pleural EAS are limited, and misdiagnosis often occurs.
The present study reports the case of a 31-year-old patient diagnosed with primary pleural EAS with lung and bone metastases. The patient presented with persistent right chest pain for 5 months and dyspnea for 2 months. Chest computed tomography (CT) scan revealed right hydropneumothorax, diffuse thickening of the right pleura, passive atelectasis, and scattered nodules in the left lung. A medical thoracoscopic pleural biopsy revealed a vasogenic tumor. To further confirm the diagnosis, positron emission tomography/CT (PET/CT) examination was recommended to determine the biopsy site after multidisciplinary discussion. Increased 18F-FDG uptake in the right pleura and hypermetabolic nodules in the right chest wall, first lumbar vertebrae, second sacral vertebrae, and bilateral iliac crest was detected via PET/CT. CT-guided chest wall and lung biopsies were performed. Immunohistochemistry of specific markers was performed according to remote consultation with a pathologist, and tumor cells with strong positive expression of CD31, CD34, and ETS-related genes led to the final diagnosis of primary pleural EAS.
Primary pleural EAS should be considered for hydropneumothorax of an unknown cause. PET/CT can accurately locate the lesion. The pathological examination is the basis for primary pleural EAS diagnosis. Moreover, multidisciplinary discussion and remote expert consultation can improve the diagnosis rate of primary pleural EAS.
原发性胸膜上皮样血管肉瘤(EAS)是一种极其罕见的肿瘤,无特异性临床症状。原发性胸膜EAS的临床资料有限,误诊屡见不鲜。
本研究报告了一例31岁诊断为原发性胸膜EAS伴肺和骨转移的患者。患者出现持续右胸痛5个月,呼吸困难2个月。胸部计算机断层扫描(CT)显示右侧液气胸、右侧胸膜弥漫性增厚、肺不张以及左肺散在结节。内科胸腔镜胸膜活检显示为血管源性肿瘤。为进一步确诊,多学科讨论后建议进行正电子发射断层扫描/CT(PET/CT)检查以确定活检部位。PET/CT检测到右侧胸膜18F-FDG摄取增加以及右胸壁、第一腰椎、第二骶椎和双侧髂嵴处代谢亢进结节。进行了CT引导下胸壁和肺活检。根据与病理学家的远程会诊进行了特异性标志物的免疫组化检查,CD31、CD34和ETS相关基因呈强阳性表达的肿瘤细胞最终确诊为原发性胸膜EAS。
对于病因不明的液气胸应考虑原发性胸膜EAS。PET/CT可准确定位病变。病理检查是原发性胸膜EAS诊断的基础。此外,多学科讨论和远程专家会诊可提高原发性胸膜EAS的诊断率。